In this conference report an overview of the highlights from the 6th JBF Symposium is provided.
Scientific or regulated validation: a tiered approach? Meeting report from a joint EBF/DVDMDG workshop
This conference report presents a summary of discussions between the Delaware Valley Drug Metabolism Discussion Group and the EBF on the tiered approach.
Defining the challenges of the modern analytical laboratory (CPSA USA 2014): the risks and reality of personalized healthcare
This article is a conference report from the 17th Annual Symposium on Clinical and Pharmaceutical Solutions through Analysis (CPSA). The CPSA USA 2014 focused on the various challenges facing the modern bioanalytical laboratory.
Close to sixty scientists from across Western Europe gathered for the Peptide Bioanalysis Forum held on-site at Ferring Pharmaceuticals A/S in Copenhagen on February 3 – 4, 2015.
This is a conference report on the 10th annual Applied Pharmaceutical Analysis conference, which focused on: Regulated Bioanalysis, Biotransformation, and Discovery.
7th GCC Insights: incurred samples use; fit-for-purpose validation, solution stability, electronic laboratory notebook and hyperlipidemic matrix testing
The 7th Global CRO Council for Bioanalysis (GCC) brought together 46 senior-level participants from six countries, representing 37 bioanalytical CRO companies/sites. Multiple topics of current interest in bioanalysis were discussed, including issues in performing ISS and fit-for-purpose method validation.
EBF Lecture – How alternative bioanalytical technologies can assist clinical safety and efficacy assessment
Bioanalysis experts from Intertek, the leading quality solutions provider to industries worldwide, will present a lecture at the European Bioanalysis Forum (EBF) on the advantages that alternative bioanalytical technologies can bring to clinical safety and efficacy assessment of new drugs.
The 9th Workshop on Recent Issues in Bioanalysis will be held 13–17 April 2015 in Miami (FL, USA).
Interview with George Scott & Geoff Moran (InVentiv Health Clinical) on the evolving role of CROs in bioanalysis
In this interview we discuss how CROs are taking an increasingly active, collaborative role in research, and what that means for inVentiv Health Clinical and the wider marketplace.
Intertek announces the expansion of its immunochemistry facility in San Diego with a move to a larger center of excellence.